The in vivo interaction between flavone acetic acid and hyperthermia

International Journal of Hyperthermia

Volumn 12, Issue 6, 1996, Pages 779-789

  Horsman, M R ^a   Sampson, L E ^b   Chaplin, D J ^b   Overgaard, J ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

C3H mouse mammary carcinoma; Flavone acetic acid; Hyperthermia; Normal foot skin; Tumour necrosis factor

Indexed keywords

MITOFLAXONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; FOOT; HEAT INJURY; HEATING; HYPERTHERMIC THERAPY; MOUSE; NONHUMAN; REACTION TIME; TISSUE INJURY; TUMOR BLOOD FLOW;

EID: 0029801166     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609027684     Document Type: Article

References (47)

1. BIBBY, M. C., DOUBLE, J. A., PHILLIPS, R. M., and LOADMAN, P. M., 1987, Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). British Journal of Cancer, 55, 159-163.
2. BIBBY, M. C., DOUBLE, J. A., LOADMAN, P. M., and DUKE, C. V., 1989, Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. Journal of the National Cancer Institute, 81, 216-220.
3. CAPOLONGO, L. S., BALCONI, G., UBEZIO, P., GIAVAZZI, R., TARABOLETTI, G., REGONESI, A., YODER, O. C., and D'INCALCI, M., 1987, Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent. European Journal of Cancer Clinical Oncology, 23, 1529-1535.
4. CORBETT, T. H., BISSERY, M. C., WOZNIAK, A., PLOWMAN, J., POLIN, L., TAPAZOGLOU, E., DIECKMAN, J., and VALERIOTE, F., 1986, Activity of flavone acetic acid (NSC-347512) against solid tumors of mice. Investigation of New Drugs, 4, 207-220.
5. CRILE, G., 1963, The effects of heat and radiation on cancers implanted on the feet of mice. Cancer Research, 23, 372-380.
6. DEWHIRST, M. W., PRESCOTT, D. M., CLEGG, S., SAMULSKI, T. V., PAGE, R. L., THRALL, D. E., LEOPOLD, K., ROSNER, G., ACKER, J. C., and OLESON, J. R., 1990, The use of hydralazine to manipulate tumour temperatures during hyperthermia. International Journal of Hyperthermia, 6, 971-983.
7. EDWARDS, H. S., BREMNER, J. C. M., and STRATFORD, I. J., 1991, Induction of hypoxia in the KHT sarcoma by tumour necrosis factor and flavone acetic acid. International Journal of Radiation Biology, 59, 419-432.
8. EVELHOCH, J. L., BISSERY, M. C., CHABOT, G. G., SIMPSON, N. E., MCCOY, C. L., HEILBRUN, L. K., and CORBETT, T. H., 1988, Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Research, 48, 4749-4755.
9. FINLAY, G. J., SMITH, G. P., FRAY, L. M., and BAGULEY, B. C., 1988, Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect. Journal of the National Cancer Institute, 80, 241-245.
10. FUJIMOTO, S., KONNO, C., KOBAYASHI, K., KOKUBUN, M., SHRESTHA, R. D., KIUCHI, S., TAKAHASHI, M., OHTA, M., and OKUI, K., 1991, Augmented antitumour effects of combined treatment with hyperthermia and tumour necrosis factor on human gastric cancer xenotransplanted into nude mice. International Journal of Hyperthermia, 7, 511-518.
11. GERWECK, L. E., NYGAARD, T. G., and BURLETT, M., 1979, Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Research, 39, 966-972.
12. HILL, S. A., and DENEKAMP, J., 1978, The effect of vascular occlusion on the thermal sensitization of a mouse tumor. British Journal of Radiology, 51, 997-1002.
13. HILL, S. A., WILLIAMS, K. B., and DENEKAMP, J., 1989, Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. European Journal of Cancer and Clinical Oncology, 25, 1419-1424.
14. HONESS, D. J., HU, D. E., and BLEEHEN, N. M., 1991, A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour. International Journal of Hyperthermia, 7, 667-679.
15. HORSMAN, M. R., CHAPLIN, D. J., and OVERGAARD, J., 1991, The effect of combining flavone acetic acid and hyperthermia on the growth of a C3H mammary carcinoma in vivo. International Journal of Radiation Biology, 60, 385-388.
16. HORSMAN, M. R., CHRISTENSEN, K. L., and OVERGAARD, J., 1989, Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. International Journal of Hyperthermia, 5, 123-136.
17. JAIN, R. K., GRANTHAM, F. H., and GULLINO, P. M., 1979, Blood flow and heat transfer in Walker 256 mammary carcinoma. Journal of the National Cancer Institute, 62, 927-933.
18. KALLINOWSKI, F., MOEHLE, R., and VAUPEL, P., 1989, Substantial enhancement of tumor hyperthermic response by tumor necrosis factor. Hyperthermic Oncology, Vol. 1, edited by T. Sugahara and M. Saito (London: Taylor and Francis), pp. 258-259.
19. KALMUS, J., OKUNIEFF, P., and VAUPEL, P., 1990, Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSaII tumors. Cancer Research, 50, 15-19.
20. KERR, D. J., MAUGHAN, T., NEWLANDS, E., RUSTIN, G., BLEEHEN, N. M., LEWIS, C., and KAYE, S. B., 1989, Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. British Journal of Cancer, 60, 104-106.
21. LAWS, A. L., MATTHEW, A. M., DOUBLE, J. A., and BIBBY, M. C., 1995, Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid. British Journal of Cancer, 71, 1204-1209.
22. LIN, P. S., HO, K. C., and SUNG, S. J., 1993, Combined treatments of heat, radiation and cytokines with flavone acetic acid on the growth of cultured endothelial cells. International Journal of Hyperthermia, 9, 517-528.
23. MACE, K. F., HORNUNG, R. L., WILTROUT, R. H., and YOUNG, H. A., 1990, Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer. Cancer Research, 50, 1742-1747.
24. MAHADEVAN, V., MALIK, S. T. A., MEAGER, A., FIERS, W., LEWIS, G. P., and HART, I. R., 1990, Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Research, 50, 5537-5542.
25. OVERGAARD, J., 1980, Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. International Journal of Radiation Oncology, Biology and Physics, 6, 1507-1517.
26. OVERGAARD, J., and BICHEL, P., 1977, The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro. Radiology, 123, 511-514.
27. OVERGAARD, J., and NIELSEN, O. S., 1980, The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia. Annals of the New York Academy of Sciences, 335, 254-280.
28. PATTERSON, J., and STRANG, R., 1979, The role of blood flow in hyperthermia. International Journal of Radiation Oncology, Biology and Physics, 5, 235-241.
29. PLOWMAN, J., NARAYANAN, V. L., DYKES, D., SZARVASI, E., BRIET, P., YODER, O. C., and PAULL, K. D., 1986, Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Cancer Treatment Reports, 70, 631-635.
30. SAKAGUCHI, Y., MAEHARA, Y., BABA, H., KUSUMOTO, T., SUGIMACHI, K., and NEWMAN, R. A., 1992, Flavone acetic acid increases the antitumor effect of hyperthermia in mice. Cancer Research, 52, 3306-3309.
31. SAPIRSTEIN, L. A., 1958, Regional blood flow by fractional distribution of indicators. American Journal of Physiology, 193, 161-168.
32. SCHROYENS, W. A., DODION, P. F., SANDERS, C., LOOS, M., DETHIER, N. E., DELFORGE, A. R., STRYCKMANS, P. A., and KENIS, Y., 1987, In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015). European Journal of Cancer Clinical Oncology, 23, 1135-1139.
33. SMITH, G. P., CALVELEY, S. B., SMITH, M. J., and BAGULEY, B. C., 1987, Flavone acetic acid (NSC 347512) induced haemorrhagic necrosis of mouse colon 26 and 28 tumours. European Journal of Cancer and Clinical Oncology, 23, 1209-1211.
34. STORM, F. K., 1983, Hyperthermia in Cancer Therapy, (Boston, MA: G.K. Hall Publishers).
35. SUIT, H. D., 1975, Hyperthermia in the treatment of tumours. Proceedings of the International Symposium on Cancer Therapy by Hyperthermia and Radiation, Washington, 28-30 April (American College of Radiology), pp. 107-114.
36. SUN, J. R., and BROWN, J. M., 1989, Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. Cancer Research, 49, 5664-5670.
37. TEICHER, B. A., HOLDEN, S. A., RUDOLPH, M. B., SOTOMAYOR, E. A., and HERMAN, T. S., 1991, Effect of environmental conditions (pH, oxygenation and temperature) on the cytotoxicity of flavone acetic acid and its dimethylaminoethyl ester. International Journal of Hyperthermia, 7, 905-915.
38. TOMASOVIC, S. P., VASEY, T. A., STORY, M. D., STEPHENS, L. C., and KLOSTER-GAARD, J., 1994, Cytotoxic manifestations of the interaction between hyperthermia and TNF: DNA fragmentation. International Journal of Hyperthermia, 10, 247-262.
39. VAN DER ZEE, J., VAN DEN AARDWEG, G. J. M. J., VAN RHOON, G. C., VAN DEN BERG, A. P., and DE WIT, R., 1995, Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in rats. British Journal of Cancer, 71, 1158-1162.
40. VAUPEL, P., 1979, Oxygen supply to malignant tumors. Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors, edited by H. I. Peterson (Boca Raton, Florida: CRC Press Inc.), pp. 143-168.
41. VOORHEES, W. D., and BABBS, C. F., 1982, Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. European Journal of Cancer and Clinical Oncology, 19, 1027-1033.
42. WALLEN, C. A., COLBY, T. V., and STEWART, J. R., 1986, Cell kill and tumor control after heat treatment with and without vascular occlusion in RIF-1 tumors. Radiation Research, 106, 215-223.
43. WATANABE, N., NIITSU, Y., UMENO, H., SONE, H., NEDA, H., YAMAUCHI, N., MAEDA, M., and URUSHIZAKI, I., 1988, Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Research, 48, 650-653.
44. WATTS, M. E., MURRAY, J. C., SMITH, K. A., and WOODCOCK, M., 1992, Flavone acetic acid as a modifier of endothelial cell function. International Journal of Radiation Oncology Biology and Physics, 22, 431-435.
45. WIKE-HOOLEY, J. L., HAVEMAN, J., and REINHOLD, H. S., 1984, The relevance of tumor pH to the treatment of malignant disease. Radiotherapy and Oncology, 2, 343-366.
46. ZWI, L. J., BAGULEY, B. C., GAVIN, J. B., and WILSON, W. R., 1989, Blood flow failure as a major determinant in the antitumour action of flavone acetic acid. Journal of the National Cancer Institute, 81, 1005-1013.
47. ZWI, L. J., BAGULEY, B. C., GAVIN, J. B., and WILSON, W. R., 1990, The use of vascularized spheriods to investigate the action of flavone acetic acid on tumour blood vessels. British Journal of Cancer, 62, 231-237.